"Ramping up production of two novel vaccines at a very large scale in the same facility is unprecedented. But the government decided that given the critical need, Emergent should manufacture both drug substances simultaneously," Mr. Kramer said.
Emergent BioSolutions CEO: We take 'full responsibility' for vaccine mishap
→
